These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6721467)

  • 21. Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability.
    Stoeckel K; Hofheinz W; Laneury JP; Duchene P; Shedlofsky S; Blouin RA
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2602-6. PubMed ID: 9756762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative trial of pivmecillinam/pivampicillin and amoxycillin/clavulanate in the therapy of urinary tract infection in a general practice population.
    O'Dowd TC; Ribeiro CD; Smail JE; Menday AP; Howells CH
    Curr Med Res Opin; 1984; 9(5):310-5. PubMed ID: 6397334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dose-ranging study of cefuroxime axetil in the treatment of lower respiratory tract infections in general practice.
    Spencer RC; Griggs JV; Brown GW
    Drugs Exp Clin Res; 1987; 13(2):101-3. PubMed ID: 3582133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pivmecillinam plus pivampicillin in complicated urinary tract infection. Double-blind comparison of the combination pivmecillinam/pivampicillin and pivmecillinam alone in patients with urinary tract infection.
    Frimodt-Møller C; Vejlsgaard R
    J Int Med Res; 1981; 9(4):283-7. PubMed ID: 6266897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of pivmecillinam and pivampicillin in the treatment of enteric fever.
    Tanphaichitra D; Srimuang S; Chiaprasittigul P; Menday P; Christensen OE
    Infection; 1984; 12(6):381-3. PubMed ID: 6569851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.
    Gooch WM; Blair E; Puopolo A; Paster RZ; Schwartz RH; Miller HC; Smyre HL; Yetman R; Giguere GG; Collins JJ
    Pediatr Infect Dis J; 1996 Feb; 15(2):157-64. PubMed ID: 8822290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM; Brown GW; Cox DM
    Drugs Exp Clin Res; 1987; 13(2):91-4. PubMed ID: 3582135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pivmecillinam plus pivampicillin in urinary tract infections. A double-blind comparison with pivmecillinam alone in hospitalized patients.
    Saltvedt EP; Schøyen R
    Infection; 1982 Jan; 10(1):21-2. PubMed ID: 6279521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pivmecillinam plus pivampicillin versus co-trimoxazole in patients undergoing transurethral prostate resection.
    Holmquist B; Lundgren R
    Pharmatherapeutica; 1984; 3(10):686-91. PubMed ID: 6087368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
    Lang CC; Moreland TA; Davey PG
    J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short course therapy with cefuroxime axetil for acute otitis media: results of a randomized multicenter comparison with amoxicillin/clavulanate.
    Pessey JJ; Gehanno P; Thoroddsen E; Dagan R; Leibovitz E; Machac J; Pimentel JM; Marr C; Leblanc F
    Pediatr Infect Dis J; 1999 Oct; 18(10):854-9. PubMed ID: 10530579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the combination pivampicillin/pivmecillinam compared to placebo in the treatment of convalescent carriers of nontyphi Salmonella.
    Svenungsson B; Ekwall E; Hansson HB
    Infection; 1990; 18(3):163-5. PubMed ID: 2194971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of pivmecillinam/pivampicillin and amoxycillin in acute exacerbations of chronic bronchitis.
    Atkins MJ; Talbot DJ
    J Int Med Res; 1987; 15(2):115-20. PubMed ID: 3556261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin.
    Sjövall J; Magni L; Bergan T
    Antimicrob Agents Chemother; 1978 Jan; 13(1):90-6. PubMed ID: 626496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in man.
    Ehrnebo M; Nilsson SO; Boréus LO
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):429-51. PubMed ID: 529016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of a short perioperative course with pivampicillin/pivmecillinam in transurethral prostatic resection: bacteriological results.
    Grabe M; Forsgren A
    Scand J Infect Dis; 1986; 18(6):575-81. PubMed ID: 3643648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term, low-dose treatment with pivmecillinam alone and in combination with pivampicillin in patients prone to recurrent bacteriuria.
    Barclay RP; Mejlhede A; Nilsson LB
    Curr Med Res Opin; 1982; 8(2):82-8. PubMed ID: 6286255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pivampicillin/pivmecillinam in the treatment of shigella carriers.
    Ekwall E; Svenungsson B
    Scand J Infect Dis; 1990; 22(5):623-4. PubMed ID: 2259872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy.
    Holme E; Greter J; Jacobson CE; Lindstedt S; Nordin I; Kristiansson B; Jodal U
    Lancet; 1989 Aug; 2(8661):469-73. PubMed ID: 2570185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of amdinocillin and pivamdinocillin in normal volunteers.
    Neu HC; Srinivasan S; Francke EL; Ortiz-Neu C; Christenson JG
    Am J Med; 1983 Aug; 75(2A):60-4. PubMed ID: 6311007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.